StopDownOpen the app

IPO · Healthcare & Life Sciences

Integris Medtech files for initial public offering

By ·

Date
Company
Integris Medtech Ltd
What it does
Medical device and technology manufacturer
Kind
IPO
Amount
₹925 Cr
Stage
ipo
Based in
Hyderabad
Sector
Healthcare & Life Sciences

What they do

Integris Medtech develops and manufactures medical devices and healthcare solutions through its various subsidiaries

What happened

The company filed for an IPO (initial public offering; first sale of stock to the public) comprising a fresh issue of ₹925 crore

Why it matters

Proceeds from the fresh issue will primarily be used to repay or prepay existing debt held by its various subsidiaries

The details

  • Integris Medtech filed draft papers for an IPO to raise up to ₹925 crore through a fresh issue of shares.
  • The offering includes an offer for sale (existing shareholders selling their stakes) of over 21.6 million equity shares.
  • Promoter shareholders including Evercure Holdings, Gurmit Singh Chugh, and Punita Sharma are participating in the offer for sale.
  • The company may consider a pre-IPO placement (private share sale before public listing) of up to ₹185 crore.
  • Any pre-IPO placement will reduce the total size of the fresh issue by up to 20 percent.
  • The shares will be listed on the NSE (National Stock Exchange) in Mumbai.

The bigger picture

  • The company plans to use the fresh capital to repay or prepay borrowings of its subsidiaries.
  • Subsidiaries benefiting from the debt reduction include Translumina Therapeutics, Transhealth, and HaleMed Medical Private Limited.
  • The company was previously known as Integris Health Private Limited.

About the business

  • Integris Medtech operates as a medical technology company focused on healthcare solutions.
  • The firm manages operations through multiple wholly-owned and step-down subsidiaries.
  • The company maintains its registered office in the Financial District of Hyderabad.
  • The business model involves manufacturing and distributing medical devices to healthcare providers.
  • The company utilizes a book building process to determine the final share price for investors.

What happens next

  • The company will determine the final price band and minimum bid lot size before the public launch.

The deal

Type
IPO

Investors

  • Evercure Holdings Pte. Ltd. (seller) — A promoter shareholder participating in the offer for sale.
  • Gurmit Singh Chugh (seller) — A promoter shareholder participating in the offer for sale.
  • Punita Sharma (seller) — A promoter shareholder participating in the offer for sale.

Read it as a card in the app

Same day

All startup news on 12 September 2026 →